Human cytochrome P450 (CYP) genes:: recommendations for the nomenclature of alleles

被引：44

作者：

Ingelman-Sundberg, M ^{[1
]}

Daly, AK

Oscarson, M

Nebert, DW

机构：

[1] Karolinska Inst, IMM, Div Mol Toxicol, SE-17177 Stockholm, Sweden

[2] Univ Newcastle Upon Tyne, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[3] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA

[4] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA

来源：

PHARMACOGENETICS | 2000年 / 10卷 / 01期

关键词：

SNP; drug metabolism; human genome;

D O I：

10.1097/00008571-200002000-00012

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：91 / 93

页数：3

共 7 条

[1]

Antonarakis SE, 1998, HUM MUTAT, V11, P1

[2] Nomenclature for human CYP2D6 alleles [J].

Daly, AK ;

Brockmoller, J ;

Broly, F ;

Eichelbaum, M ;

Evans, WE ;

Gonzalez, FJ ;

Huang, JD ;

Idle, JR ;

IngelmanSundberg, M ;

Ishizaki, T ;

JacqzAigrain, E ;

Meyer, UA ;

Nebert, DW ;

Steen, VM ;

Wolf, CR ;

Zanger, UM .

PHARMACOGENETICS, 1996, 6 (03) :193-201

[3] Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment [J].

Ingelman-Sundberg, M ;

Oscarson, M ;

McLellan, RA .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :342-349

[4] Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].

Lazarou, J ;

Pomeranz, BH ;

Corey, PN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205

[5]

NEBERT DW, 2000, IN PRESS PHARMACOGEN, V10

[6] Sequence variation in the human angiotensin converting enzyme [J].

Rieder, MJ ;

Taylor, SL ;

Clark, AG ;

Nickerson, DA .

NATURE GENETICS, 1999, 22 (01) :59-62

[7]

SHOWS TB, 1987, CYTOGENET CELL GENET, V46, P11

← 1 →